Teva, Mylan and fellow valsartan makers have to face consumer fraud claims: judge

A New Jersey federal judge on Friday tossed out consumers' fraud claims against distributors of generic valsartan blood pressure drugs but waved through allegations against manufacturers themselves.

U.S. District Judge Robert Kugler allowed a variety of fraud allegations to proceed against a suite of valsartan drugmakers that consumers say knowingly sold their products tainted with the probable carcinogen N‐nitrosodimethylamine (NDMA).